According to a research report from Morgan Stanley, based on CRRC (01766)'s first nine months performance, the target price has been raised from HK$5 to HK$5.60, while the "Underweight" rating is maintained.
The bank slightly lowered its 2026 revenue forecast for the company by 1%, but raised its 2027 revenue forecast by 1% due to a more stable growth outlook. For net profit forecasts, the 2026 figure was cut by 3%, while the 2027 figure was roughly kept unchanged.
The bank has rolled its valuation forward to 2027, keeping the target price-to-earnings ratio unchanged at 8 times. While the bank appreciates the company's defensive qualities, it believes the valuation does not appear attractive enough given the flat growth prospects.
Comments